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Background: Luminal water imaging (LWI) suffers less from imaging artifacts than the diffusion-weighted imaging used in
multiparametric MRI of the prostate. LWI obtains multicompartment tissue information from a multiecho T2 dataset.
Purpose: To compare a simpliﬁed LWI technique with apparent diffusion coefﬁcient (ADC) in classifying lesions based on
groupings of PI-RADS v2 scores. Secondary aims were to investigate whether LWI differentiates between histologically
conﬁrmed tumor and normal tissue as effectively as ADC, and whether LWI is correlated with the multicompartment
parameters of the vascular, extracellular, and restricted diffusion for cytometry in tumors (VERDICT) diffusion model.
Study Type: A subset of a larger prospective study.
Population: In all, 65 male patients aged 49–79 were scanned.
Field Strength/Sequence: A 32-echo T2 and a six b-value diffusion sequence (0, 90, 500, 1500, 2000, 3000 s/mm
2) at 3T.
Assessment: Regions of interest were placed by a board-certiﬁed radiologist in areas of lesion and benign tissue and
given PI-RADS v2 scores.
Statistical Tests: Receiver operating characteristic and logistic regression analyses were performed.
Results: LWI classiﬁes tissue as PI-RADS 1,2 or PI-RADS 3,4,5 with an area under curve (AUC) value of 0.779, compared
with 0.764 for ADC. LWI differentiated histologically conﬁrmed malignant from nonmalignant tissue with AUC, sensitivity,
and speciﬁcity values of 0.81, 75%, and 87%, compared with 0.75, 83%, and 67% for ADC. The microstructural basis of the
LWI technique is further suggested by the correspondence with the VERDICT diffusion-based microstructural imaging
technique, with α, A1, A2, and LWF showing signiﬁcant correlations.
Data Conclusion: LWI alone can predict PI-RADS v2 score groupings and detect histologically conﬁrmed tumors with an
ability similar to ADC alone without the limitations of diffusion-weighted MRI. This is important, given that ADC has an
advantage in these tests as it already informs PI-RADS v2 scoring. LWI also provides multicompartment information that
has an explicit biophysical interpretation, unlike ADC.
Level of Evidence: 3
Technical Efﬁcacy: Stage 2
J. MAGN. RESON. IMAGING 2018.
PROSTATE CANCER (PCa) is the second most commoncancer in the UK, accounting for 13% of all new cases, and
the second most common cause of cancer death in males.1–4
The suspicion of PCa is typically assessed using multiparametric
magnetic resonance imaging (mp-MRI) images, including
T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI),
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and dynamic contrast-enhanced (DCE) measurements,5 which
are then scored using an ordinal scale, most commonly the
Prostate Imaging Reporting and Data System (PI-RADS) v2
scheme.6,7 mp-MRI provides sensitivity and speciﬁcity values
of between 87–93% and 41–47%, respectively, in the detec-
tion of clinically signiﬁcant prostate cancer when used on a
1.5 T scanner.8
Current limitations of mp-MRI are that its speciﬁcity
when detecting tumors is low8 and there is only a moderate
interreader agreement across all lesions (55–65%).9 PI-RADS
v2.0 on a 1.5 T scanner also classiﬁes 35.6–44.7% of lesions
as indeterminate,8 meaning that the method cannot distin-
guish whether a large number of cases are clinically signiﬁcant
prostate cancer or not, although in practice the classiﬁcation
may vary depending on the radiologist, the patient popula-
tion, and the image quality. Furthermore, echo planar imag-
ing (EPI)-based diffusion scans often suffer from distortion,
signal pile-up, or stretching artifacts,10 leading to less accurate
results and in some circumstances unusable images. Different
studies have tried to solve some of these issues, particularly
with regard to reducing the proportion of lesions classiﬁed as
indeterminate,11,12 but none has conclusively solved them.
The tissue within the prostate has three major compo-
nents: luminal space, epithelial cells, and stromal cells, as
shown in Fig. 1. The luminal space stores the ﬂuid produced
by the surrounding epithelial cells and the stromal cells form
a matrix surrounding these compartments, giving the prostate
structure and forcing the ﬂuid out of the prostate during
ejaculation. The luminal water imaging (LWI) technique
models two compartments, one the luminal space with a dis-
tribution of long T2 values and the other both the stromal
and epithelial cells with a distribution of short T2 values. The
vascular, extracellular, and restricted diffusion for cytometry
in tumors (VERDICT) technique models three compart-
ments: the intracellular compartment, which represents the
restricted diffusion of the epithelial cells, the extracellular-
extravascular compartment, which represents hindered dif-
fusion within the luminal space and stroma, and the vascular
compartment. The diffusivity values for the intracellular and
extracellular-extravascular compartments are assumed to be
the same and of a lower value than the pseudo-diffusivity of
the vascular compartment.
The prostate is made up of a number of separate tissue
zones. Each is made up of different proportions of gland,
stroma, and epithelia. The central zone consists of large,
irregularly shaped glands, cuboidal epithelial cells, and com-
pact stromal tissue. The peripheral zone contains small, reg-
ularly arranged glands lined by columnar epithelial cells and
surrounded by loosely interwoven stroma. The transition
zone, composed of two lobules either side of the urethra,
closely resembles the peripheral zone tissue.
Storas et al13 found that a multiecho T2 (ME-T2)
sequence is consistently better at probing tissue microstruc-
ture than a single echo T2 sequence, showing that in the
prostate a mono-exponential ﬁt is only adequate for
describing the underlying tissue in 10% of the subjects.
Sabouri et al14 implemented a method to investigate quan-
titative T2 imaging in the prostate, proposing the LWI
technique, which produces an estimate of the fractional
volume of luminal water in each voxel of the prostate, the
luminal water fraction (LWF). Sabouri et al14 have shown
that there is a good correlation between LWF and histolog-
ically measured luminal fractional volume and determined
that LWI shows promise in being able to detect PCa and
predict Gleason score.15 However, the ﬁtting method used
has a high number of degrees of freedom, potentially mak-
ing it vulnerable to noise and local minima. They used an
echo train with 64 echoes, which is not available on all
scanners. In addition, compared with using fewer echoes, a
64 echo train may be more vulnerable to the cumulative
FIGURE 1: Diagram of prostate histology in (a) benign tissue (b) malignant adenocarcinoma. The four separate microenvironments
present in the prostate are shown in the key. Using LWI, the short-T2 component is made up of the stroma and epithelia and the
long-T2 component is made up of the lumen (the T2 of the vasculature is not considered to have a signiﬁcant effect on the LWI
model). Using the VERDICT model, the intracellular compartment is made up of epithelia, the extracellular-extravascular
compartment is made up of stroma, and lumen and the vascular compartment is made up of the vasculature.
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effects of imperfect refocusing pulses and have a higher
speciﬁc absorption rate.
Materials and Methods
Simulation
A simulation was used to compare alternative methods for ﬁtting the
LWF. Signals from a tissue with a distribution of T2 values were
simulated. Datasets typical of both acquisition schemes were used
(Sabouri et al: echo time [TE] = 25 msec, number of echoes
[NE] = 64; this study: TE = 31.25 msec, NE = 32) and two separate
datasets were created on different assumptions about the underlying
T2 distribution, one using two Gaussian peaks and the other using
two delta peaks. The values used for the shorter T2 compartment
were 20, 50, and 80 msec and for the longer T2 compartment were
300, 550, and 800 msec. Using a value of signal-to-noise ratio
(SNR) of 100 and for ground truth LWF values of 0, 0.1, and 0.2
(a range typical of both tumor and normal tissue,14) the LWF was
calculated from ﬁts to each set of conditions.
Patient Selection
In vivo data were acquired on a subcohort of 65 patients from a
larger prospective study.17 The study received UK Research
Ethics Committee approval on December 23, 2015. Patients were
recruited between September 2016 and October 2017 and pro-
vided written informed consent following a minimum 24-hour
period of consideration. The patient inclusion criteria were 1)
men referred for prostate mp-MRI following previous biopsy
more than 6 months earlier, and 2) biopsy-naive men presenting
a clinical suspicion of prostate cancer. Patient exclusion criteria
included 1) men unable to have an MRI scan, or in whom artifact
would reduce the quality of the MRI, 2) men unable to give
informed consent, 3) previous treatment (prostatectomy, radio-
therapy, brachytherapy) of prostate cancer, 4) ongoing hormonal
treatment for prostate cancer, and 5) previous biopsy within
6 months of scheduled mp-MRI. Five subjects were excluded
throughout the course of this study, four due to MR contraindi-
cations and one due to a technical fault. In this study an assess-
ment was made on a broad range of subjects, including men for
whom it was decided a biopsy was not necessary.
MRI Acquisitions
Subjects were scanned on a 3.0 T scanner (Philips Achieva; Phi-
lips Medical Systems, Best, The Netherlands) using a 32-channel
cardiac coil. A multiecho spin-echo sequence with an echo spac-
ing of 31.25 msec and repetition time (TR) of 8956 msec was
used. The other parameters were: NE = 32; ﬁeld of view
(FOV) = 180 × 180 mm; acquired voxel size = 2 × 2 × 4 mm;
scan duration = 5 minutes 50 seconds. DWI was acquired for
VERDICT ﬁtting with single diffusion encoding (SDE) single-
shot EPI sequences over six b-values (0, 90, 500, 1500, 2000,
3000 s/mm2). TR/TE=2000–3707/50–80msec; FOV=220× 220mm;
voxel size = 1.3 × 1.3 × 5 mm; scan duration = 12:57.16 A standard
mp-MRI protocol was also conducted on these patients, as detailed in
previous work.17
Regions of Interest (ROIs) and Histologic
Examination
A board-certiﬁed radiologist with 5 years of experience in pros-
tate mp-MRI reporting (F.G.) contoured 97 areas of either malig-
nant or benign tissue. The lesions had previously been located in
the mp-MRI images and the primary lesions were then located
and contoured in a single slice of the 93.75 msec echo of the
ME-T2 image with no knowledge of the LWI maps. In the case
of malignant tissue the entire lesion was outlined, whereas in
healthy tissue the ROI from the lesion was copied into a region
of healthy tissue in the same prostate zone. The 93.75 msec echo
was chosen for its similar echo time to a traditional axial T2
weighted prostate image (~100 msec). In all, 98 ROIs were also
contoured on the corresponding slice of the ADC maps. These
ROIs were drawn to directly correspond to those contoured on
the ME-T2 images. The number of ROIs were slightly different
in the ADC and ME-T2 images due to two ME-T2 images having
not been correctly acquired and one ADC image having a large
artifact in the ROI. Each area of benign tissue or lesion was
assigned a PI-RADS v2 score based on the standard mp-MRI
images, acquired in addition to the VERDICT and ME-T2
images. PI-RADS v2 is a method of scoring tissue on a scale of
1–5, with 1 meaning clinically signiﬁcant cancer is highly
unlikely to be present and 5 meaning clinically signiﬁcant cancer
is highly likely to be present. In the peripheral zone (PZ) of the
prostate, where the majority of tumors arise, this scoring is pri-
marily informed by diffusion images, with axial T2 and DCE
images used when the diffusion image is indeterminate. Histolog-
ical grading using a targeted transperineal template biopsy was
available on a subset of 31 of the ROIs. The Gleason grading sys-
tem was used to evaluate the biopsy tissue samples.18 Our pri-
mary analysis uses ROIs drawn without knowledge of the LWF
maps to avoid bias. If LWF maps are used directly in the future,
an indication of reproducibility between readers will be informa-
tive. In a substudy of 16 patient datasets, two separate readers
each drew 16 ROIs on the LWF maps themselves and the median
parameter values were evaluated using a correlation and Bland–
Altman analysis.
Data Processing
Sabouri et al14 used a regularized nonnegative least squares
(NNLS) algorithm to ﬁt a multiexponential model. The NNLS
algorithm ﬁts a large number of exponentials (>100) to the signal
decay curve, including a regularizing term in the error minimiza-
tion to compensate for problems associated with having a large
number of unknown variables compared with the number of ech-
oes. A large number of exponentials also seems inappropriate
because in previous works,13–15 only two compartments were usu-
ally identiﬁed in the prostate gland.
Hence, for this work we have constrained the model to two
compartments, each with a Gaussian probability distribution of T2
values. The choice of Gaussians is a mathematically simple choice
and, based on preliminary analysis, the difference between Gaussian,
log-Gaussian, and gamma distributions made little difference to the
overall ﬁt of the signal decay. Hence a two-Gaussian model was
ﬁtted to the individual T2 signal decay curves using a least-squares
regression. These two Gaussian distributions model the tissue as a
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combination of a luminal compartment with long T2 values and a
compartment composed of stroma and epithelia with shorter T2
values. The probability density p over T2 value T2 in a particular
pixel is given by:
p T 2ð Þ¼ α
σ1
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2π
p exp − T 2−μ1ð Þ
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with the signal intensity S at each echo time TE subsequently calcu-
lated as:
S¼M0
ð∞
0
p T 2ð Þ:exp − TE
T 2
 
dT 2 ð2Þ
This model ﬁtting minimizes the mean squared error
between the actual signal and the modeled signal, using the
Levenberg–Marquardt algorithm to optimize over six parameters:
the absolute signal magnitude (M0), the magnitude ratio between
the two peaks (α), the means of the two components (μ1 and μ2),
and the variances of the two components (σ1 and σ2). The values of
μ1 and μ2 were constrained to be 0–200 msec and 200–3000 msec,
respectively; none of the other parameters were constrained. The start-
ing values for the constrained model for M0, μ1, and μ2 were calcu-
lated once for each subject by taking an average intensity for each
echo over all pixels in the prostate and carrying out a biexponential
ﬁt on the averaged signal decay across the ROI. This study used
the short and long T2 values of the biexponential ﬁt as initial esti-
mates for μ1 and μ2 and the mean of the magnitudes of each expo-
nential as the initial estimate for M0. Initial values of σ1 and σ2
were set at 5 × 10-4, which was in the range of the standard devia-
tion of the NNLS peaks in previous LWI ﬁttings. This reduction
in the number of parameters compared with the unconstrained
model should provide a more reliable ﬁt and operate using fewer
data points, permitting echo trains with fewer echo signals.
The areas under the individual peaks, A1 for the shorter T2
peak and A2 for the longer T2 peak, were calculated by integrating
the respective Gaussians using their magnitude, mean, and variance.
The LWF was then calculated as the fraction of the total area under
the distribution curve attributed to the peak with the longer T2:
LWF ¼A2= A1 +A2ð Þ ð3Þ
For each of these parameters a map was created across the
entire prostate. Then the ROIs produced earlier on the 93.75 msec
echo of the ME-T2 image were superimposed onto these parameter
maps and the median values of these parameters were calculated for
each ROI. All data were processed using MatLab (MATLAB and
Statistics Toolbox Release 2017a, MathWorks, Natick, MA).
The VERDICT model, when applied to the prostate, is a
three-compartment diffusion-based microstructural model that char-
acterizes water diffusion into vascular, intracellular (IC), and
extracellular-extravascular space (EES) compartments. The IC com-
partment has volume fraction (fIC), diffusivity (dIC), and cell radius
(R) as parameters. The EES compartment has volume fraction
(fEES) and diffusivity (dEES) as parameters. The vascular model has
volume fraction (fVASC) and pseudo-diffusivity (P) as parameters.
Statistics
In order to create a 95% conﬁdence interval for the simulation data,
bias corrected and accelerated percentile bootstrapping was used on
1000 bootstrap samples.
Differences were characterized between the median parameter
values of ROIs with different PI-RADS v2 groupings of scores and
determined using a logistic regression model combined with 5-fold
TABLE 1. Mean Estimated LWF Values for Both the Constrained and Unconstrained Models Using Different Ground
Truth LWF Values in Simulation
Ground truth LWF
Pulse sequence Model ﬁtting 0 0.1 0.2
32-echo &
31.25 msec echo
spacing
Two-Gaussian 0.0074 (0.0019,0.0747) 0.1001 (0.0918,0.1174) 0.1913 (0.1817,0.2605)
32-echo &
31.25 msec echo
spacing
NNLS 0.0003 (0.0002,0.0005) 0.0867 (0.0827,0.0900) 0.1802 (0.1691,0.1884)
64-echo & 25 msec
echo spacing
Two-Gaussian 0.0008 (0.0004,0.0104) 0.0976 (0.0914,0.1042) 0.1996 (0.1905,0.2203)
64-echo & 25 msec
echo spacing
NNLS 0.0003 (0.0002,0.0040) 0.0900 (0.0859,0.0957) 0.1829 (0.1698,0.1885)
The mean values using both the delta and Gaussian ground truth models over a range of μ1 and μ2 values. In brackets are the 95% con-
ﬁdence interval bounds.
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crossvalidation. Three comparisons were made in this way. The
comparison between the scores PI-RADS 1,2 vs. PI-RADS 3,4,5
aims to divide those lesions needing further action from those that
do not. The other two comparisons, PI-RADS 1,2 vs. PI-RADS
3, and PI-RADS 3 vs. PI-RADS 4,5, both aim to investigate the
model’s ability to discern between the three main categories of nega-
tive (1,2), indeterminate (3), and positive (4,5) disease. P < 0.05 was
taken to be signiﬁcant. The mean values for sensitivity, speciﬁcity,
and area-under-curve (AUC) values across the ﬁve-folds were also
computed using a receiver operating characteristic (ROC) analysis.
Sensitivity and speciﬁcity values were calculated from the ROC anal-
ysis using an operating point with the shortest distance to the point
of perfect discrimination. A logistic regression was performed on the
median values of those ROIs with a corresponding histological grad-
ing in order to discern malignant (Gleason 3 + 3 and above) from
nonmalignant tissue.
To detect signiﬁcant statistical differences between the values
of AUC for LWF and ADC when predicting PI-RADS v2 catego-
ries, a Kruskal–Wallis nonparametric statistical test was performed
on the AUC values of each of the ﬁve-folds of the crossvalidation.
To detect signiﬁcant statistical differences between the values of
AUC for LWF and ADC when predicting Gleason categories, a
Kruskal–Wallis nonparametric statistical test was performed on 1000
bootstrapped examples. For both the PI-RADS v2 and Gleason
Score Kruskal–Wallis tests, P < 0.05 would suggest with 95% conﬁ-
dence that the null hypothesis (that the AUC values of ADC and
LWF come from the same distribution) be rejected.
In order to assess the relationship between LWI and the VER-
DICT diffusion model for prostate,16 a Pearson’s correlation coefﬁ-
cient was calculated between the VERDICT fIC, fEES, fVASC
parameters and each of the parameters of LWI separately. The fIC
parameter is of particular interest due to the fact that it has previ-
ously shown signiﬁcant difference between PCa and normal tissue18
and that it represents the cellular compartment within the tissue,
and hence might be expected to negatively correlate with the LWF.
A standard Bland–Altman analysis was carried out on the
median values within the subset of 16 ROIs to analyze the reproduc-
ibility of this method.
Results
The age range of the 65 patients was 49–79 years with a mean of
65. Of the T2 ROIs with PI-RADS v2 scoring, there were 31 PI-
RADS 1, 32 PI-RADS 2, 18 PI-RADS 3, 5 PI-RADS 4, and
11 PI-RADS 5. Similarly for the diffusion ROIs, there were
30 PI-RADS 1, 32 PI-RADS 2, 18 PI-RADS 3, 7 PI-RADS
4, and 11 PI-RADS 5. Of the histologically examined ROIs,
16 were found to be benign, three were Gleason 3 + 3, six were
3 + 4, three were 4 + 3, two were 4 + 4, and one was 4 + 5.
The simulation results in Table 1 show that the proposed
two-Gaussian method with 32 echoes has a similar accuracy
to the original LWI at determining the LWF over a range of
ground truth tissue models.
Table 2 shows the results of the statistical tests for in vivo
PI-RADS v2 score groupings.
Table 3 presents the comparison of the proposed method
with histologically conﬁrmed malignant lesions and shows values
of 0.81 and 0.75 (AUC), 75% and 83% (sensitivity), and 87%
and 67% (speciﬁcity), respectively, for LWF and ADC.
Table 4 shows the results of Kruskal–Wallis tests designed
to test whether there is a signiﬁcant difference between the AUC
TABLE 2. Three Separate Analyses Using LWF and ADC to Predict PI-RADS v2 Scores
Scores 1,2v3 3v4,5 1,2v3,4,5
Test P-val. AUC Sens. Spec. P-val. AUC Sens. Spec. P-val. AUC Sens. Spec.
LWF 0.0047 0.7857 63.3 84.0 0.0129 0.8667 80.0 76.7 0.0001 0.8809 80.6 78.7
ADC 0.3947 0.6546 48.7 80.9 0.0805 0.7467 73.3 79.3 0.0346 0.6909 59.4 77.4
The P-value comes from the logistic regression model and the other statistics are from an ROC analysis.
TABLE 3. ROC Analysis of LWF in Detecting Malignant
Lesions (Gleason 3 + 3 and Above)
Variable AUC Sensitivity Speciﬁcity
LWF 0.81 75% 87%
ADC 0.75 83% 67%
TABLE 4. P-values of Kruskal-Wallis Tests Between
ADC and LWF for the ROC Analyses Performed on
Each of the Four Score Groupings Tested
Score groupings P-value
PI-RADS 1,2 v 3 0.0758
PI-RADS 3 v 4,5 0.1246
PI-RADS 1,2 v 3,4,5 0.0758
Gleason 3 + 3 and above 0.7771
A P-value of 0.05 means that the null hypothesis, that the ADC
and LWF predictions have the same AUC values, can be
rejected with 95% conﬁdence.
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values produced by ADC and those produced by LWF. These
tests were performed on each of the four score groupings investi-
gated. In none of the comparisons made can the results prove
with 95% conﬁdence that the ADC and LWF are producing
signiﬁcantly different AUC values.
Table 5 shows the correlations between the individual
parameters of the LWI model and three parameters from the
VERDICT diffusion model. With respect to fIC, signiﬁcant
positive correlations greater than 0.5 were seen for α and A1
and signiﬁcant negative correlations less than –0.5 were seen
for A2 and LWF. With respect to fEES, signiﬁcant positive
correlations greater than 0.5 were seen for A2 and LWF and
signiﬁcant negative correlations less than –0.5 were seen for
α. None of the LWI parameters show a correlation greater
than 0.5 or less than –0.5 with fVASC.
Figure 2 shows the LWF map for one patient alongside
the axial-T2 and ADC maps from the same subject. Note the
higher LWF in the PZ, consistent with histological ﬁndings
of large regular glandular lumen and loosely woven stroma in
the PZ.
Figure 3 shows graphs for the T2 distributions from sin-
gle example voxels in healthy and cancerous tissue, respec-
tively. Clear changes in the distributions are visible.
The Bland–Altman analysis of the median LWF values
of the subset of 16 ROIs produced an r2 value of 0.928, a
bias of 0.013, and limits of agreement of –0.151 and 0.124,
with a mean value of 0.179.
Discussion
The main aim of this work was to compare a simpliﬁed LWI
with ADC for the prediction of PI-RADS v2 scores. The LWF
predictions showed similar AUC values to ADC, suggesting that
LWF is able to discriminate between clinically relevant PI-RADS
v2 groupings of scores as well as ADC. Given that the PI-RADS
v2 scoring scheme uses ADC as a major component and might
thus be expected to favor ADC, it is interesting to ﬁnd that
LWI alone can predict PI-RADS v2 score as well as ADC alone.
The ability of LWF to differentiate tumor from normal tissue
using histologically examined ROIs further reinforces the idea
that multiecho T2 modeling shows promise as a method for
detecting and grading PCa.
Our results suggest that LWI may be a useful tool in
PCa detection. If using the LWF measure in the future, ROIs
may be drawn directly on LWF maps, in which case the
repeatability between readers is an important consideration.
TABLE 5. Correlation Between LWI Parameters and the Intracellular Fraction (fIC), Extracellular-Extravascular
Fraction (fEES), and Vascular Fraction (fVASC) Parameters of the VERDICT Diffusion Model
M0 α μ1 μ2 σ1 σ2 A1 A2 LWF
fIC Corr. 0.3935 0.6197 –0.1313 0.2518 0.0253 0.2715 0.516 –0.6017 –0.6184
P-value 0.0003 0.0000 0.2458 0.0242 0.8237 0.0148 0.0000 0.0000 0.0000
fEES Corr. –0.2319 –0.5411 0.0690 –0.2735 0.0576 –0.2612 –0.3635 0.5825 0.5644
P-value 0.0385 0.0000 0.5429 0.0141 0.6121 0.0193 0.0009 0.0000 0.0000
fVASC Corr. –0.1700 –0.0812 0.0591 0.0650 –0.0965 –0.0041 –0.1618 0.0024 0.0384
P-value 0.1317 0.4739 0.6026 0.5670 0.3945 0.9711 0.1515 0.9834 0.7355
FIGURE 2: LWF map, axial T2 image, and ADC map for one patient. The region of healthy tissue is highlighted by the arrow on the
left of each image, the tumor by the arrow on the right of each image. This ﬁgure shows distortions in the PZ in the diffusion-
weighted image, highlighting a disadvantage of DWI over ME-T2 modeling.
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The correlation and Bland–Altman analysis carried out on a
subset of our patients provides an indication of the expected
variability. A more extensive quantiﬁcation of the value of
LWI in PCa detection requires larger and multicenter studies
and the results presented here can inform those studies.
The correlations between LWI and the VERDICT
model are intended to give an insight into how LWI relates
to tissue microstructure. An increase in LWF represents an
increase in the fractional volume of luminal space within the
prostate. As PCa typically invades the luminal space and
reduces the luminal fractional volume, a reduced LWF value
is expected within a tumor. The parameters with signiﬁcant
correlations greater than 0.5 in magnitude suggest that as the
volume fraction of the luminal space decreases the volume
fraction of the intracellular compartment increases and the
volume fraction of the extracellular-extravascular compartment
decreases.16 These correlations with the VERDICT model
parameters suggest that LWI is sensitive to the underlying tissue
microstructure.
MRI is utilized in the prostate for the detection and
staging of tumors. LWI allows for the collection of micro-
structural information without the distortion artifacts seen in
diffusion imaging. In the future, it might be that either less
diffusion data need to be acquired, or that complementary
information from LWI improves the efﬁcacy of mp-MRI
given the different tissue compartments that they are designed
to probe. Further sequence optimization to increase coverage
of the prostate and reducing the thickness of the slices would
be beneﬁcial prior to testing on a much larger number of sub-
jects and across multiple centers. A future prospective assess-
ment should also include a multiple reader study to quantify
the variability introduced by radiological placement of ROIs.
Although a PI-RADS score can be allocated to any
lesion, a limitation of this study is that not all patients subse-
quently received biopsy, limiting the ability to perform full
histological correlations. Another limitation is that biopsy is
prone to sampling error, which can lead to the undergrading
of tumors.19 Sampling error could be reduced by using
whole-mount histopathology but this would lead to a bias in
the Gleason grades of the lesions studied due to the fact that
radical prostatectomies are only carried out on subjects with
more signiﬁcant lesions. Furthermore, the subjects in this
study were a subset of a larger prospective study,17 meaning
that the analysis done in this article was retrospective. A larger
number of subjects could prove more conclusively the hypoth-
esis that LWI performs at least as well as ADC in discerning
the PI-RADS v2 score and Gleason score. This would allow
for a reduced number of protocols for grading prostate cancer,
reducing overall scan times. The AUC for the detection of
PCa is also lower in this study than previous results,15 possibly
due to previous studies using patients scheduled for retropubic
prostatectomy, weighting the lesions towards more advanced
tumors.
In conclusion, this work suggests that LWI is sensitive
to the tissue microstructure and can be as effective as ADC in
the classiﬁcation of lesions using the PI-RADS V2 scores
while providing images with minimal distortions.
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